On the stock market since 2009, it operates in the world of health and science. It has 3 employees. Now — the numbers.
The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.
Average growth of 13% a year over the last 4 years. Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Cost Efficiency: As sales grow, profit fails to keep the same pace.
An investor who bought at the very peak is down 100% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
There is $332K in the vault; even if every debt were paid off, $332K would remain.
A loss of $49K against $98K in annual sales. And on top of that, sales fell from the year before.
The stock sits at $0.0003. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
On our five-subject report card, CBDL sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: CBDL is a small company that closed last year at a loss. The road back to profit runs through spending discipline.